AyuVis Research is an early stage drug discovery biopharmaceutical focused on developing New Molecular Entity (NME)/ New Technologies as anti-infective, immune modulating and anti-inflammatory drugs. AyuVis is developing proprietary small molecule therapeutics having the potential to transform the treatment prospects for patients with sepsis, severe sepsis, septicemia as well as inflammatory diseases such as dry and wet age related macular degeneration.
